Danimer Scientific, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 12.7 million compared to USD 14.47 million a year ago. Net loss was USD 30.45 million compared to net income of USD 39.25 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to basic earnings per share from continuing operations of USD 0.44 a year ago. Diluted loss per share from continuing operations was USD 0.3 compared to diluted earnings per share from continuing operations of USD 0.39 a year ago.
For the six months, revenue was USD 27.45 million compared to USD 27.65 million a year ago. Net loss was USD 56.83 million compared to USD 55.49 million a year ago. Basic loss per share from continuing operations was USD 0.56 compared to USD 0.64 a year ago. Diluted loss per share from continuing operations was USD 0.56 compared to USD 0.64 a year ago.